KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $102,000 | 0.0% | 18,857 | +7.1% | 0.00% | 0.0% |
Q3 2021 | $102,000 | -94.6% | 17,613 | -90.1% | 0.00% | -95.7% |
Q1 2021 | $1,880,000 | +132.1% | 178,704 | +318.7% | 0.02% | +109.1% |
Q2 2020 | $810,000 | +180.3% | 42,680 | +183.9% | 0.01% | -38.9% |
Q1 2020 | $289,000 | -82.7% | 15,036 | -82.7% | 0.02% | -56.1% |
Q4 2019 | $1,669,000 | -39.1% | 87,067 | -69.5% | 0.04% | -48.8% |
Q3 2019 | $2,742,000 | +348.0% | 285,100 | +172.0% | 0.08% | +281.0% |
Q1 2019 | $612,000 | -46.8% | 104,800 | -14.7% | 0.02% | -52.3% |
Q4 2018 | $1,151,000 | -83.8% | 122,800 | -70.6% | 0.04% | -86.1% |
Q3 2018 | $7,121,000 | +0.8% | 418,100 | +0.6% | 0.32% | -17.2% |
Q2 2018 | $7,061,000 | +44.1% | 415,600 | +0.7% | 0.38% | +4.4% |
Q1 2018 | $4,900,000 | +104.2% | 412,892 | +65.2% | 0.37% | +86.3% |
Q4 2017 | $2,400,000 | -12.6% | 250,000 | 0.0% | 0.20% | -21.5% |
Q3 2017 | $2,745,000 | -6.7% | 250,000 | -23.1% | 0.25% | -17.2% |
Q2 2017 | $2,941,000 | -32.6% | 325,000 | -4.4% | 0.30% | -30.8% |
Q1 2017 | $4,366,000 | – | 340,000 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |